Search Results - "ELSHEIKH, Somaia E"

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes by RAKHA, Emad A, ELSHEIKH, Somaia E, EVANS, Andy J, BLAMEY, Roger, REIS-FILHO, Jorge S, FOULKES, William D, ELLIS, Ian O, ALESKANDARANY, Muhammed A, HABASHI, Hany O, GREEN, Andrew R, POWE, Desmond G, EL-SAYED, Maysa E, BENHASOUNA, Ahmed, BRUNET, Jean-Sébastien, AKSLEN, Lars A

“…Purpose: Triple-negative (TN; estrogen receptor, progesterone receptor, and HER-2 negative) cancer and basal-like breast cancer (BLBC) are associated with poor…”
Get full text

Growth fraction as a predictor of response to chemotherapy in node‐negative breast cancer by Aleskandarany, Mohammed A., Green, Andrew R., Rakha, Emad A., Mohammed, Rabab A., Elsheikh, Somaia E., Powe, Desmond G., Paish, Emma C., Macmillan, R. Douglas, Chan, Steve, Ahmed, Samreen I., Ellis, Ian O.

“…Accurate predictive markers of chemotherapeutic response in early breast cancer are still lacking. The role of tumour growth fraction as a predictor of…”
Get full text

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome by ELSHEIKH, Somaia E, GREEN, Andrew R, GRAINGE, Matthew J, BALL, Graham R, ABDELGHANY, Magdy K, MARTINEZ-POMARES, Luisa, HEERY, David M, ELLIS, Ian O, RAKHA, Emad A, POWE, Des G, AHMED, Rabab A, COLLINS, Hilary M, SORIA, Daniele, GARIBALDI, Jonathan M, PAISH, Claire E, AMMAN, Amr A

“…Post-translational histone modifications are known to be altered in cancer cells, and loss of selected histone acetylation and methylation marks has recently…”
Get full text